Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer

Andrea Coccia1, Luciana Mosca2, Rosa Puca1

  • 1Department of Medical‑Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.

Oncology Reports
|October 18, 2016
PubMed

Insights

Extra-virgin olive oil extract (EVOOE) shows significant antiproliferative effects on bladder cancer cells. EVOOE also modulates chemotherapy efficacy, suggesting potential health benefits and new anticancer strategies.

Area of Science:

  • Oncology
  • Nutraceuticals
  • Molecular Biology

Background:

  • Epidemiological studies link Mediterranean diet, rich in extra-virgin olive oil (EVOO), to reduced cancer incidence, particularly bladder cancer.
  • EVOO is known for its rich polyphenol content, which possess antioxidant and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the antiproliferative effects of EVOO polyphenols on bladder cancer (BCa) cells.
  • To elucidate the mechanisms of cell death induced by EVOO extract (EVOOE).
  • To evaluate EVOOE's ability to modulate the in vitro activity of paclitaxel and mitomycin C.

Main Methods:

  • In vitro cell culture of T24 and 5637 BCa cell lines.
  • Assessment of cell proliferation, clonogenic ability, and cell cycle progression.
  • Induction of apoptosis and reactive oxygen species (ROS) production analysis.
  • Combination treatments with EVOOE and standard chemotherapeutic agents.

Main Results:

  • EVOOE demonstrated dose-dependent inhibition of proliferation and clonogenic growth in BCa cells.
  • EVOOE induced G2/M cell cycle arrest in both cell lines and apoptosis in T24 cells.
  • Co-treatment with mitomycin C and EVOOE reduced drug cytotoxicity by inhibiting ROS production.
  • Co-treatment with paclitaxel and EVOOE significantly enhanced apoptotic cell death in T24 cells.

Conclusions:

  • EVOO polyphenols exhibit significant anti-BCa activity, supporting epidemiological findings.
  • EVOOE can modulate the efficacy of chemotherapeutic agents, offering potential for novel combination therapies.
  • These findings suggest EVOO consumption may contribute to cancer prevention and provide a basis for developing new anticancer strategies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K